By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

GTX Corp 

117 West 9th Street
Suite 1214
Los Angeles  California  90015  U.S.A.
Phone: 213-489-3019 Fax: 213-489-3062


SEARCH JOBS


Industry
Diagnostics






Company News
GTX Corp Reports Results From Ongoing Enobosarm Phase 2 Clinical Trial In ER+/AR+ Breast Cancer 12/8/2016 12:43:17 PM
GTX Corp Achieves Second Stage 1 Milestone In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer 11/16/2016 11:53:13 AM
GTX Corp Announces $14.0 Million Registered Direct Common Stock Offering 10/12/2016 2:41:09 PM
GTX Corp Announces Initiation Of Phase 2 Clinical Trial Of Enobosarm In Stress Urinary Incontinence 1/13/2016 10:16:35 AM
GTX Corp Receives FDA Clearance To Initiate Clinical Trial In Stress Urinary Incontinence 10/13/2015 12:55:29 PM
GTX Corp Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of Enobosarm In Triple Negative Breast Cancer 10/6/2015 11:37:11 AM
GTX Corp Provides Corporate Update And Reports Second Quarter 2015 Financial Results 8/6/2015 12:10:57 PM
GTX Corp Announces Webcast Of Corporate Presentation At Jefferies 2015 Global Healthcare Conference 5/26/2015 10:57:10 AM
GTX Corp Announces Webcast Of Corporate Presentation At The UBS Global Healthcare Conference 2015 5/12/2015 11:23:24 AM
GTX Corp Provides Corporate Update And Reports First Quarter 2015 Financial Results 5/8/2015 11:45:56 AM
12345
//-->